Rika Kihara

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

Rika Kihara, Yasunobu Nagata, Hitoshi Kiyoi et al. · Leukemia · 2014 · 233 citations · Full text

Life Sciences, Genetics, Oncology +17

A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia

Kosuke Tsuboi, Toshiya Yokozawa, Toru Sakura et al. · Leukemia Research · 2011 · 55 citations

Medicine, Pharmacokinetics, Pharmacology +9

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study

Yasuhiko Harada, Yasunobu Nagata, Rika Kihara et al. · Leukemia Research · 2018 · 50 citations · Full text

Life Sciences, Genetics, Hematology +17

Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells

Naomi Kawashima, Yuichi Ishikawa, Jeong Hui Kim et al. · Nature Communications · 2022 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +14

Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study

Naomi Kawashima, Akimi Akashi, Yasunobu Nagata et al. · Annals of Hematology · 2018 · 25 citations · Full text

Medicine, Genetics, Molecular Genetics +14